Adial Pharmaceuticals Inc.

ADIL | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.40

-$0.46 (-9.47%)

At close: Sep 21, 2026, 4:00 PM ET

$4.48

+$0.08 (+1.82%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-7.98M	-13.2M	-7M	-12.73M	-19.42M	-10.89M
Depreciation & Amortization	565	565	564	60.5K	55.11K	564
Stock-Based Compensation	676.2K	796.83K	1.75M	3.37M	4.24M	2.01M
Other Working Capital	108.87K	215.13K	-634.79K	-1.48M	1.82M	620.23K
Other Non-Cash Items	342.13K	5.09M	-757.66K	-522K	1.81M	1.56M
Deferred Income Tax	n/a	n/a	n/a	-502	-94.08K	-1.56M
Change in Working Capital	465.67K	386.14K	-794.21K	-1.37M	1.46M	1.25M
Operating Cash Flow	-6.49M	-6.92M	-6.81M	-11.19M	-11.95M	-7.63M
Capital Expenditures	3	n/a	6.81M	n/a	-64.61K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	30.59K	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	150K	n/a	1.5M	n/a	n/a	-350K
Investing Cash Flow	150K	n/a	1.5M	n/a	-34.02K	-350K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-1.66K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	3.82M	n/a	1.87K	1.89M	450.01K
Financial Cash Flow	8.47M	7.85M	4.13M	9.13M	13.64M	5.61M
Net Cash Flow	2.13M	923.44K	-1.17M	-2.06M	1.66M	-2.38M
Free Cash Flow	-6.49M	-6.92M	n/a	-11.19M	-12.01M	-7.63M
Adj. Free Cash Flow	-7.17M	-7.72M	-1.75M	-14.56M	-16.25M	-9.65M
Maintenance CapEx	-3	n/a	-564	n/a	-55.11K	n/a
Growth CapEx	6	n/a	6.81M	n/a	-9.5K	n/a
Owner Earnings	-6.49M	-6.92M	-6.81M	-11.19M	-12M	-7.63M